Challenges and Opportunities for Clinical Research in the Middle East
Semra Yoruk and Emel Tetik
Affiliation: Radiation Oncologist, Sanofi Clinical Study Unit, Turkey & Middle East Cluster, Turkey.
This review article discusses the current challenges and future trends on research and development (R&D) activities.
Development of a new medicine becomes more complicated, challenging and expensive as well as more risky because
of further obstacles during the registration. Clinical Research phases of R&D consume more than two thirds of the
development cost. So sponsors will be veered towards business operations that offer cost savings, consistency, quality,
and enhancements in clinical trial productivity. Gigantic changes in technology bring more challenges and opportunities
to industry, clinical researchers and healthcare givers. Joint efforts by sponsors/contract research organizations, research
institutes, universities and regulatory authorities are needed to shape the clinical research in the future, especially the
Middle East and North Africa region.
Keywords: Attractiveness, attractive properties, challenges, clinical research, Middle East, Middle East and North Africa,
Mena region, research and development.
Rights & PermissionsPrintExport